ACRES Commercial Realty (ACR) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
6 Nov, 2025Executive summary
Reported GAAP net income allocable to common shares of $9.8 million, or $1.34 per share, for Q3 2025, driven by a $13.1 million gain from a real estate investment sale and redeployment of proceeds into new loans.
Book value per share increased to $29.63 from $27.93 sequentially, reflecting a 12.7% annual increase since Q3 2020.
Focus remains on building a high-quality investment pipeline, growing EAD, and executing share repurchases to enhance shareholder value.
75% of the loan portfolio is multifamily-focused, with 92.3% of loans current on payments as of September 30, 2025.
Entered into the Fourth Amendment to the Master Repurchase and Securities Contract Agreement with Morgan Stanley, increasing the facility to $400 million, with potential up to $500 million under certain conditions.
Financial highlights
GAAP net income per diluted share was $1.34; EAD per diluted share was $1.01 for Q3 2025.
Net income allocable to common shares for Q3 2025 was $9.8 million, up from $2.8 million in Q3 2024.
Realized gain from CRE equity investment totaled $13.1 million.
GAAP book value per share increased to $29.63 from $27.93 sequentially.
Total liquidity at quarter-end was $64.5 million, including $41 million in cash.
Outlook and guidance
Expects substantial new loan closings in Q4, aiming for positive portfolio growth for the full year.
Targeting a book value objective of approximately $30 per share as remaining properties are sold.
Dividend payments anticipated to resume after asset monetization and book value targets are met.
Illustrative earnings profile projects potential EAD per share up to $3.16 and GAAP EPS up to $1.75 at higher portfolio and leverage levels, though not formal guidance.
Latest events from ACRES Commercial Realty
- $571M in new loans, $3M net loss, book value up to $30.01, and $1B CRE CLO closed.ACR
Q4 20255 Mar 2026 - Net income and book value rose, with 79% of loans in multifamily and strong liquidity.ACR
Q2 20242 Feb 2026 - Q3 2024 net income rose to $2.8M, book value per share hit $27.92, and liquidity stayed strong.ACR
Q3 202417 Jan 2026 - Q1 net loss, portfolio contraction, and new $939.9M facility amid elevated credit risk.ACR
Q1 202524 Dec 2025 - Book value and EAD rose on asset sales; strong multifamily loans and portfolio growth expected.ACR
Q4 202424 Dec 2025 - Annual meeting to vote on directors, Say on Pay, auditor, and highlight ESG and governance.ACR
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.ACR
Proxy Filing1 Dec 2025 - Q2 2025 saw a net loss, $27.93 book value per share, and a $1.4B CRE loan portfolio.ACR
Q2 202516 Nov 2025